National Cancer Centre Singapore
National Cancer Centre Singapore
Singapore, Singapore, Singapore1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ETC-159 In Combination With Pembrolizumab In Advanced MSS/pMMR Ovarian Cancers | With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer | Recruiting | Phase 1 | 2025-07-25 | NCT06513624 |